Detalhe da pesquisa
1.
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.
Lancet
; 392(10157): 1541-1551, 2018 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262332
2.
Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.
J Endovasc Ther
; 26(2): 158-167, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30702021
3.
Nitinol stent implantation for femoropopliteal disease in patients on hemodialysis: results of the 3-year retrospective multicenter APOLLON study.
Heart Vessels
; 31(9): 1476-83, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26337619
4.
Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
Circulation
; 127(23): 2307-15, 2013 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23652861
5.
Duplex criteria for in-stent restenosis in the superficial femoral artery.
Catheter Cardiovasc Interv
; 81(4): E199-205, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22639187
6.
Two-year Clinical Outcomes Post Implantation of EpicTM Self-Expanding Nitinol Stents for the Aortoiliac Occlusive Disease in Patients with Peripheral Arterial Disease.
J Atheroscler Thromb
; 25(4): 344-349, 2018 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978866
7.
Timing of nitinol stent restenosis in superficial artery disease: one year is good enough?
Catheter Cardiovasc Interv
; 78(4): 618, 2011 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21953757
8.
Impact of changing PSVR thresholds on the patency rates of SFA recanalisation with self-expanding nitinol stents.
EuroIntervention
; 9(8): 964-7, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24384293